Science Entrepreneur Club

🌟 What an incredible milestone for the SEC's BioEntrepreneur Club! 🌟 This achievement is a testament to the vibrant and collaborative community that we've built together. We believe that fostering connections between life sciences founders and the broader ecosystem is key to driving innovation. 💡 As we continue to grow, it’s inspiring to see how our events and initiatives are sparking meaningful conversations and empowering the next generation of bio-entrepreneurs. Let’s keep building, learning, and celebrating together. 🚀 👉 If you’re in life sciences and haven’t joined us yet, now’s the perfect time! #BioEntrepreneurClub #LifeSciences #Innovation #Community

🧬 Forge Genetics' Next Milestone Is Strategic Partnerships 🌟 In a recent #Interview, Ariyana Rayatt sat down with Forge Genetics to uncover their next big steps in gene editing. 🔬 Forge Genetics is leveraging their innovative Forge Editing technology to offer safer and simpler strain developments. The team is advancing from bacterial cells to mammalian gene editing—targeting proof of concept by 2025 and safety data by 2027. 🚀 Forge Genetics' unique approach has achieved remarkable traction early on, generating over £1.3 million in revenue within their first year—setting them apart in the biotech world. 🧩 With their sights set on the gene therapy market, they are exploring how their second-mover advantage can navigate regulatory pathways and provide a compelling alternative to CRISPR-based therapies. Read the full story 👉 https://lnkd.in/eb6hiyag If you’re a C-suite or founder building in bio, join the BioEntrepreneur Club here 👉 https://lnkd.in/ej886h2V #GeneEditing #Innovation #Biotech #Startups

For #startups and investors, join DxPx Conference EU ’25 to explore opportunities in #fundraising, M&A, licensing, and financing. Engage with investors and industry partners passionate about Diagnostics, Digital Health, Precision Medicine, and Life Science Tools. 👉 500+ participants: Including 100+ venture capitalists, corporate VCs, and other investors focused on non-therapeutic life sciences 👉 20 exhibitors: Showcasing cutting-edge innovations in our Startup City 👉 4 expert panels: Insights from industry leaders and investors 👉 1 pitch award: 8 selected companies, chosen by 30+ VCs, will compete for up to $2,000,000 in convertible loans Reception: Sunday, January 26th, 2025 Partnering Day & 42PLUS1: January 27th, 2025 Munich, Germany Venue: Leonardo Royal Munich Don’t miss this unique platform for #lifesciences collaboration and growth! Get your ticket here: https://lnkd.in/d8RMMfvp Important: If you are an SEC #BioEntrepreneur Member or a #BioCapital Member, contact the SEC Team for tickets 😃

Thinking of starting a life science company but don't know where to start and with whom? We are excited to announce the launch of a new community: BioMatch Network, where aspiring life science entrepreneurs can meet potential cofounders, refine business ideas and get a complete orientation on the UK ecosystem for life science startups! 🗓 First social event: 15th January 2025 Academics 🎓, Industry experts 👨💼👩💼, Startup employees 🚀: come out of your shell and apply to the community here: https://lnkd.in/eNJxprRw Required: ✅ Technical or commercial expertise in life sciences ✅ Entrepreneurial mindset Not (strictly) required: ❌ IP ❌ Team ❌ Solid business idea Please share this post with your contacts dreaming of founding a lifesci startup 🌟 #entrepreneurs #innovation #founders #lifesciences

This week on the #InnovatorsClub, Cohort V gathered for the last time at our Celebration Showcase. Having completed our 10 week pre-accelerator programme, each of the eight companies from Cohort V delivered a rapid-fire three minute pitch to the #BioCapitalNetwork followed by a good few hours of relaxed and celebratory networking with over 40 life science investors in the room. 🫶 Cohort V has been a truly incredible programme with some exceptional entrepreneurs developing inspiring innovations. A huge thank you to each of the founders of Cohort V for your passion and enthusiasm throughout: 💉 Cambridge Medixine Ltd. - developing a novel mRNA technology platform for vaccines and therapeutics 🧫 Cellertia - developing a novel microfluidics platform for low-cost high-throughput chemical-free cell separation to support precision medicine and diagnostics (www.cellertia.com) 🩸 ClotProtect - developing a first-in-class injectable anti-fibrinolytic small molecule direct selective plasmin inhibitor for bleeding indications 🦠 Deep Blue BioTech - developing a Cyanobacteria platform to produce green chemicals, starting with hyaluronic acid 🦸♀️ EVE - developing a non-invasive, home-based testing kit capable of analysing biomarkers found in menstrual blood 💊 Medusa Pharmaceuticals - developing synergistic combinations of repurposed drugs that reinvigorate existing antibiotics to overcome AMR 💊 MOMO Biotech - developing TMEmic tumour-on-a-chip technology to predict where therapies will work best and learning from those that fail 🫁 Panthura - developing targeted nanoparticles for DNA delivery, with their first programme aiming to deliver a gene therapy for cystic fibrosis 🫶 We cannot wait to follow each of your progress and see all the amazing things you will achieve. 🏆 A huge congratulations to Alice Preston of Panthura who was announced the winner of Cohort V, taking home a prize package including three whole months of rent-free lab space at London BioScience Innovation Centre (LBIC) and a bunch of other goodies! Thanks to our judging panel Amanda, Roona and Réka for taking on the huge task of deciding the winner! 🫶 A huge thank you to the Gold sponsors of Cohort V - Marks & Clerk and London BioScience Innovation Centre (LBIC) - we wouldn't be able to do any of this without your support. 🫶 Thank you also to all of the other individuals and organisations who have supported the cohort along the way by sharing their time and expertise - Koolen Consulting Ltd., First Create The Media, Gallagher, Taylor Wessing, FTI Consulting, PNO Consultants Ltd (UK) and the many members of the #BioCapitalNetwork. Daniel Vilafranca García Matthew McCann #lifesciences #accelerator #investors #founders #venturecapital #innovation 📸 More photos to come but thanks to Irina Titkova for some sneak peaks below!

💙 CardiaTec Biosciences: Revolutionising Heart Health 🌟 In our latest #StartupSpotlight, Lucy Ahern delves into a member of our BioEntrepreneur Club, CardiaTec, a pioneering company leveraging sequencing and AI to tackle cardiovascular diseases. 👥 Founded by Raphael Peralta, Thelma Zablocki, and Namshik Han, CardiaTec is building the largest multiomics dataset focused on the human heart to unlock novel therapeutic possibilities. 🔬 CardiaTec’s approach leverages multiomics data from hearts collected across the US and UK. Through AI and network biology, they’re identifying high-impact drug targets to transform heart health. 🚀 As cardiovascular disease remains the world’s leading cause of death, CardiaTec’s recent $6.5M seed round highlights strong support for their vision and potential to drive change in heart health. Read more here 👉 https://lnkd.in/eFrTgtsW If you’re a C-suite or founder building in bio, join the BioEntrepreneur Club here 👉 https://lnkd.in/ej886h2V #CardiovascularHealth #DrugDiscovery #Innovation #Biotech

Inspiring day in sunny #Edinburgh yesterday for the Cancer Research Horizons Innovation Summit 2024! 🏴󠁧󠁢󠁳󠁣󠁴󠁿 Daniel, Matthew, Bill and Natasha were in attendance representing both their day jobs and the SEC - thanks to the Cancer Research Horizons team for giving us a stall in the “marketplace” to chat about all our not-for-profit community building in the life sciences! Active life science investor and interested in joining the next one? Join the #BioCapitalNetwork 👉 https://lnkd.in/eepcRVXQ Life science C-suite or founder interested in joining the next one? Join the #BioEntrepreneurClub 👉 https://lnkd.in/ej886h2V #cancer #oncology #innovation #founders #investors #therapeutics

This week on the #InnovatorsClub, Olaf Swanzy from PNO Consultants Ltd (UK) delivered a session on how to approach and secure grant funding, sharing his expertise and top tips from submitting hundreds of applications with life science start-ups. 💸 During the session, Olaf provided a deep dive in to a range of grant opportunities available from funding bodies such as Innovate UK, NIHR (National Institute for Health and Care Research), European Commission (EIC, Horizon, Eureka), SBRI Healthcare and others. 🫶 As an invaluable source of non-dilutive funding, these top tips are incredibly useful for our Cohort V founders as they look to grow their companies. So, a huge thank you to Olaf for delivering the workshop and sharing their expertise! 🔬 Before the session, Amanda gave the cohort a tour of the fantastic facilities on offer at London BioScience Innovation Centre (LBIC). A huge thank you to the LBIC team for hosting us again! Daniel Vilafranca García Matthew McCann Cambridge Medixine Ltd. Cellertia ClotProtect Deep Blue BioTech EVE Medusa Pharmaceuticals MOMO Biotech Panthura Innovators Club Cohort V is powered by Gold sponsors Marks & Clerk and London BioScience Innovation Centre (LBIC). #grantfunding #entrepreneurs #innovation #founders #lifesciences #grants

Not long to go until Investival Showcase 2024 from LSX - partnering for Life Science eXecutives. Matthew McCann, Natasha Barrow and Caroline Babisz will be out in full force. Reach out if you'd like a chat about our #BioCapitalNetwork, #BioEntrepreneurClub, #StartUpSpotlight articles or anything else Science Entrepreneur Club related! Members of our #BioCapitalNetwork are entitled to a free Investor ticket. Members of our #BioEntrepreneurClub are entitled to 15% off (contact us for details!) Find out more here 👉 https://lnkd.in/gpGHdnYt

🥩 Meatly: The First APHA Approved Cultivated Meat in Europe 🌟 In our latest #StartupSpotlight, Sandeep Mangrati explores Meatly, a groundbreaking startup focused on sustainable, lab-grown meat for pet food, co-founded by Owen Ensor (CEO) and Helder Cruz (CSO). 💭 By specializing in pet food, Meatly navigated regulatory hurdles and cut production costs, becoming the first APHA-approved cultivated meat company in Europe. They’re pushing innovation while addressing ethical and environmental challenges in meat production. 🚀 Discover their scalable, serum-free bioreactor technology that enables large-batch production with minimized costs, and their vision to eventually offer cultivated meat at price points comparable to traditional meats. Meatly’s commitment to sustainable solutions could transform the pet food market and beyond. 📈 Follow their journey as they scale up to pilot manufacturing, optimize bioreactors, and refine harvesting methods to bring affordable, ethical cultivated meat to market. Read more here 👉 https://lnkd.in/g_QWUxSE #SustainableFood #CultivatedMeat #PetFood #Innovation